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Open access under the ElInfestins are Kazal-type serine protease inhibitors described in the midgut of Triatoma infestans, Chagas
disease vector. Of all infestins, only infestin 1R (INF1R) does not control host blood coagulation, due to its
inhibitory speciﬁcity for chymotrypsin-like proteases. We further investigated the effect of INF1R on cell
infection by Trypanosoma cruzi. The importance of INF1R reactive site to inhibit T. cruzi cell invasion was
conﬁrmed using 1RSFTI, a synthetic cyclic peptide containing the inhibitor reactive site region hybridized
to the Sunﬂower Trypsin Inhibitor-1 (SFTI-1). Our results suggest that INF1R efﬁciently inhibited parasite
cell invasion. For the ﬁrst time, a serine protease inhibitor, derived from T. infestans, was shown to impair
cell invasion by T. cruzi, representing possible new target in parasite cell invasion.
 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction et al., 2001), and their expression increased after challenges withProteases and their inhibitors are fundamental in several biolog-
ical processes, like reproduction, development, cell cycle, immune
system, inﬂammation, angiogenesis, apoptosis, tissue remodeling,
and blood homeostasis (Lalmanach, 2008; Rawlings et al., 2004,
2008), andhavebeen shown toplaykey roles onparasite–host inter-
actions (Armstrong and Quigley, 2001). In insects, proteases and
respective inhibitors are involved in immune response regulation,
such as in Drosophila (Levashina et al., 1999) and Manduca sexta
(Kanost et al., 2004), inwhich immune response ismediated by pro-
teases related to the Toll pathway and prophenoloxidase activation,
respectively. Protease inhibitors from insects such as Galleria
mellonella inhibited parasite proteases with high afﬁnities (Nirmalawer Trypsin Inhibitor-1; 1RSFTI,
proteinase inhibitor II; PAMPs,
nhibitor concentration of 50%
ethanesulfonyl ﬂuoride hydro-
uccinyl-L-leucylamido-(4-guani-
yl; TiPI1, Triatoma infestans
e Bioquímica, Escola Paulista
FESP), Rua Três de Maio, 100,
006.
.
u Paludisme, Institut Pasteur,
sevier OA license.fungi, bacteria, and several types of antigens derived frommicroor-
ganisms, known as pathogen-associated molecular patterns
(PAMPs) (Frobius et al., 2000; Wedde et al., 1998). Ursic-Bedoya
and Lowenberger reported the identiﬁcation of immune responsive
molecules overexpressed after immune challenge in the Chagas
disease vector Rhodnius prolixus (Ursic-Bedoya and Lowenberger,
2007). In Anopheles gambiae, a malaria vector, four serpins were
described to be strongly expressed after Plasmodium ookinetes inva-
sion of females’ midgut (Danielli et al., 2003). Serpin 6 was deleteri-
ous for parasite life differentiation (Abrahamet al., 2005; Pinto et al.,
2008). It has been demonstrated by microarray that a putative
Kazal-type inhibitor from the African sleeping sickness vector
Glossina morsitans morsitansmidgut had increased expression after
exposure to Trypanosoma brucei and bacteria (Lehane et al., 2003).
Recently, several Kazal-type protease inhibitors were described as
antimicrobial agents in invertebrates.
Kazal-type protease inhibitors are represented by their ﬁrst
described member, pancreatic secretory trypsin inhibitor (PSTI,
renamed SPINK5), which compose family I1 in the MEROPS data-
base (Kazal et al., 1948; Rawlings et al., 2008). These protease
inhibitors can be found in several species as single domains or in
tandem structures expressed as single and large protein precursors
processed post-translationally. Basically, each Kazal-type domain
consists of a 6–7 kDa structured protein in two alpha-helices, three
stranded anti-parallel beta sheets and three disulﬁde bridges.
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type family also were demonstrated to play a role in immune re-
sponse against aquatic pathogens, like bacteriostatic molecules
(Augustin et al., 2009; Donpudsa et al., 2009). In different cases,
subtilisin inhibitors from Kazal-type family are related to immune
system response of invertebrates (Rimphanitchayakit and Tassa-
nakajon, 2010).
Triatoma infestans (Hemiptera: Reduviidae) is one of the most
important vectors of Chagas disease, a parasitic disease that affects
about 10 million people in Latin America (Remme et al., 2006).
Chagas disease has not been considered with the deserved atten-
tion, and despite all knowledge about Trypanosoma cruzi biology,
no optimal therapy has been developed as yet. There is neither vac-
cine nor treatment for chronic chagasic patients (Dias, 2009; Jannin
and Villa, 2007). In spite of the high prevalence, the main strategies
against Chagas disease transmission rely exclusively on vector and
blood transfusion control measures.
We have previously characterized infestin in T. infestansmidgut
as Kazal-type protease inhibitors (Campos et al., 2002). Infestins
are derived from a large precursor mRNA encoding for seven Ka-
zal-type domains, most of which are capable of blocking host blood
coagulation, except infestin1R, a single Kazal domain, which is a
subtilisin and neutrophil elastase inhibitor (Lovato et al., 2006).
Infestins are indeed required for triatomine meal acquisition and
storage, probably by preventing blood coagulation, as demon-
strated using RNAi in Triatoma brasiliensis (Araujo et al., 2007).
As proteases play key roles inT. cruzi, the agent of Chagas disease,
we investigated the role of T. infestans protease inhibitor, particu-
larly the infestin 1R domain (INF1R), on the parasite. Proteases are
crucial for growth, differentiation and cell invasion by the parasite.
Of special importance is cruzipain, a cysteine protease expressed
in all T. cruzi forms (Martinez et al., 1991; Tomas et al., 1997). Its
activity is controlled by its own inhibitor, named chagasin, which
is included in a new family of protease inhibitors due to its uncom-
mon structure (Monteiro et al., 2001). In trypomastigotes, cruzipain
is associated with cell invasion by inducing kininogen processing
andbradykinin release (Scharfstein et al., 2000). Other T. cruzi prote-
aseswhich belong toMEROPS family S9were described. Oligopepti-
dase B is involved in cell invasion by releasing a soluble Ca2+
signaling factor of unknown structure (Burleigh and Andrews,
1995; Burleigh et al., 1997). Selective inhibitors also blocked mam-
malian cell invasion by other T. cruzi S9 protease, prolyl oligopepti-
dase Tc80, which is able to hydrolyze extracellular matrix proteins
as ﬁbronectin, collagens type I and IV (Grellier et al., 2001; Bastos
et al., 2005). Another T. cruzi protease was puriﬁed from extracellu-
lar culturemedia, andwas proven to be inhibited by TPCK and TCLK.
This suggested that it is a serine protease that differs fromother pre-
viously described oligopeptidases (da Silva-Lopez et al., 2008).
In thepresent study,we investigated the INF1Rexpressionproﬁle
after blood ingestion by T. infestans and its interaction with T. cruzi.2. Materials and methods
2.1. Insects
Adult T. infestans were reared under controlled temperature
(28 ± 2.0 C), 12/12 light/dark and fed weekly on anesthetized mice
(ketamine 150 mg/kg and xylazine 7 mg/kg).2.2. Recombinant protein
INF1R was expressed inEscherichia coli and the periplasmic frac-
tion was used to purify the protein following procedures described
in (Lovato et al., 2006).2.3. cDNA synthesis and real-time quantitative PCR
Starved insects were fed on human blood in an artiﬁcial feeder
through a Paraﬁlm M membrane. Then, 107/ml parasites killed by
freezing and thawing (four cycles at temperature varying from
20 to 40 C, in PBS)were added to humanblood for infestin expres-
sion analysis. After blood meal, anterior midguts were removed for
cDNA synthesis and qPCR experiments. Total RNA from anterior
midgut of engorged insects was preserved in RNAlater RNA Stabil-
ization Reagent (QIAGEN) and then extracted using RNeasy Mini
Kit (QIAGEN) according to the manufacturer’s instructions. After
treatment with DNAse I RNase-free (Fermentas), cDNA was synthe-
sized from approximately 1.0 lg of RNA with ImProm-II™ Reverse
Transcription System (Promega) using random primers following
the manufacturer’s instructions. Relative expression levels of infes-
tin and 18S rRNA (Genbank Accession Nos. DQ309461 and Y18750)
werequantiﬁedusing SYBRGreenPCRMasterMix (AppliedBiosys-
tems) in a 7500 Fast Real-Time PCR System (Applied Biosystems).
Primer sequences were: PicINF1R 50-GCGGCCGCTCACTCTACTT-
CTTGTTC-30 and PicINF1F 50-GGTTGAATTCGAGAAAAAGGATC-
CACC-30 for infestin 1R, and 50-GGCGGGGGCATTCGTATTG-30, and
50-ATCGCTGGCTGGCATCGTTTAT-30 for 18S rRNA, according to
(Faudry et al., 2004). Quantitative PCR (qPCR) conditions were:
denaturation at 95 C for 30 s, annealing at 60 C for 1 min, and
extension at 72 C for 30 s. qPCRwas conducted in 1 ll of tenfold di-
luted INF1R cDNAand18S rRNAandprimers to a ﬁnal concentration
of 0.5 lM. For each qPCR experiment, three replicates per sample
were performed followed by dissociation curve, endogenous 18S
RNA control analysis and statistical analysis using the 7500 Fast
Real-Time PCR System program (Applied Biosystems).2.4. Cell cultivation and invasion assay
T. cruzi trypomastigotes Y strains were obtained from the super-
natant of infected LLC-MK2 monolayer cells cultivated in Dul-
becco’s modiﬁed Eagle’s medium (DMEM) supplemented with
10% FBS, at 37 C in a humidiﬁed 5% CO2 atmosphere. Trypomastig-
otes were collected from the extracellular medium 5–7 days after
infection and recovered after centrifugation at 2000g for 10 min.
LLC-MK2 cells (105 cells/ml) for invasion assays were plated in
24-well plates for 24 h. The assays were performed with freshly re-
leased parasites in a host/parasite cell ratio of 1/10 (approximately
5  106/ml) and parasites were pre-incubated for 15 min with pro-
tease inhibitors at different concentrations, before incubation with
host cells. Then, parasites were directly added to LLC-MK2 cells for
1 h. After, LLC-MK2 cells were washed three times with DMEM
without FBS and ﬁxed with 4% formaldehyde in PBS for 24 h at
4 C. After ﬁxation, cells were washed four times with PBS and
incubated with PBS-2.0% BSA for 1 h and incubated with rabbit
polyclonal antibodies against T. cruzi (Rubin-de-Celis et al., 2006)
diluted 1:100 to detect non-internalized parasites, because cells
were not permeabilized. Bound antibodies were detected by incu-
bation 1:400 with FITC-conjugated anti-rabbit IgG (Santa Cruz Bio-
technology) in PBS-0.5% BSA containing 100 lM of DAPI for 1 h.
Invasion assays were quantiﬁed by counting the number of intra-
cellular parasites in a total of 300 cells per slide. Statistical analyses
were carried out by using variance analysis with signiﬁcance level
of p < 0.05.3. 1RSFTI peptide synthesis
The cyclic peptide 1RSFTI was synthesized manually by Solid
Phase Peptide Synthesis with Fmoc strategy (Fields and Noble,
1990). Cyclization reaction was monitored by liquid chromatogra-
phy coupled to electrospray ionization mass spectrometer
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tion mediumwas acidiﬁed with acetic acid to pH range 4.5–5.0 and
lyophilized. Lactam cyclization was performed with the peptide
still attached to the resin (Miranda et al., 1994). The crude lyoph-
ilized peptides were puriﬁed to homogeneity by preparative re-
versed phase HPLC in a C18 column (Vydac). Selected fractions
containing the puriﬁed peptide were pooled and lyophilized. The
puriﬁed peptide was characterized by amino acids analysis (Beck-
man), capillary zone electrophoresis (Waters) and LC/ESI-MS
(Waters).
4. Results and discussion
Full length infestin mRNA expression was analyzed at different
times after blood feeding (6 h, 12 h, 24 h, 36 h, 7 days and 14 days).
qPCRs were performed using speciﬁc oligonucleotides which am-
plify the INF1R domain, the ﬁrst Kazal-type domain of the infestin
precursor (Fig. 1A). The qPCRs result showed a decreasing infestinFig. 1. Relative quantiﬁcation of infestin mRNA in T. infestans midgut after blood meal
signal peptide (SP) in dashed box and respective Kazal-type domains with reactive site
arrows represent the primers PicINF1F and PicINF1R used in qPCR. (B) Full length infe
arbitrarily set to 1.00 for the insects 24 h after feeding and analyses were performed re
statistically signiﬁcant (t-test, p < 0.05). (C) Infestin expression after blood meal conta
arbitrarily set to 1.00 for the insects 36 h after feeding. Differences are statistically signiﬁ
three independent experiments.precursor expression after feeding reached up to one third of origi-
nal pre-feeding levels, which occurred 24 h after blood meal. Seven
to 14 days later, infestin precursor expression returned to levels
observed for unfed insects (Fig. 1B). This recovery time is compat-
ible with the T. infestans feeding cycle (Lent and Wygodzinsky,
1979), and suggests a relationship between infestin expression
and blood feeding. It is possible that higher infestin levels are re-
quired before blood feeding in order to block host blood coagula-
tion cascade, or control other blood hazardous proteases, like
inﬂammatory related proteases from tissue and immune cells.
These results are in accordance with RNAi experiments with intes-
tinal Kazal-type precursor in T. brasiliensis called brasiliensin,
which showed a decrease in blood intake (Araujo et al., 2007).
In order to verify a possible interference of T. cruzi proteins in
infestin precursor expression after blood meal, heat-killed trypom-
astigotes, which are the protozoan form ingested by the insect vec-
tor, were added to blood. As shown in Fig. 1C, speciﬁcally after
12 h, infestin expression in insects fed on blood containing killedin artiﬁcial feeder. (A) Diagram of full length infestin cDNA representing predicted
P1–P10 amino acid residues (Schechter and Berger, 1967) in gray scale boxes. The
stin mRNA expression after feeding for 14 days. The value of infestin mRNA was
lative to 18S RNA levels previously described (Faudry et al., 2004). Differences are
ining killed T. cruzi trypomastigotes forms (Tc). The value of infestin mRNA was
cant just for 12 h versus 12 h + Tc (t-test, p < 0.05). Similar results were obtained in
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sion measured in insects that ingested pure blood (control),
remaining two times as high. No signiﬁcant differences were ob-
served among the insects fed on blood containing killed parasites
and respective controls, after 6 and 36 h. These results indicated
that the presence of parasite molecules could alter infestin expres-
sion level after blood feeding, and point to a possible signalization
in midgut, where parasite molecules could probably act as PAMPs,
known to induce host responses against pathogens. In R. prolixus,
another kissing bug species that also is a Chagas disease vector, dif-
ferent immune challenges elicited NO system response in midgut,
suggesting that kissing bugs can also recognize and respond
against pathogens, including T. cruzi (Whitten et al., 2007). Ursic-
Bedoya and Lowenberger also identiﬁed immune related mole-
cules in R. prolixus after immune challenge (Ursic-Bedoya and
Lowenberger, 2007), but the authors used injection of microorgan-
isms into hemocoel as experimental strategy, not oral infection,
which leads to quite different gene expression of immune-related
genes.
In the natural infection, T. infestans is infected by bloodstream
trypomastigote form of T. cruzi, the infective and non-replicated
life cycle form, which is released from infected cells from mamma-
lian host tissues. Despite some differences, bloodstream trypom-
astigotes are similar to trypomastigotes obtained from infected
mammalian culture cells. In order to evaluate possible interaction
between INF1R and the parasite, the recombinant inhibitor was
used in cell invasion assays. T. cruzi does not invade cells in T. infe-
stansmidgut during its life cycle and neither does it cross intestinal
epithelium, like other trypanosomes, such as Trypanosoma rangeli.
We performed cell invasion assays as a model to detect and ana-
lyze the effect of protease inhibitors during this event, specially
the effect of subtilisin inhibitors. INF1R was added to LLC-MK2 epi-
thelial cell culture, it impaired cell invasion by T. cruzi in a dose-
dependent manner. The IC50 of INF1R was between 0.1 and
1.0 lM, and INFR1 10 lM caused a drastic drop in intracellular par-
asites inside host cells (Fig. 2). No morphological and motility
alterations were observed in parasites after incubation with INF1R
and during invasion assays, by visualization under light micros-
copy (data not shown). When these ﬁndings are considered to-
gether, it is possible to suggest that INF1R inhibited cell invasion
by T. cruzi. Indeed, mainly cysteine proteases, but also other prote-
ases, like oligopeptidases, have been found to participate in T. cruziFig. 2. Effect of INF1R on epithelial cell invasion by T. cruzi trypomastigotes strain Y.
The assays were performed with freshly released parasites in a host/parasite cell
ratio of 1/10 (approximately 5  106/ml) and parasites were pre-incubated for
15 min with INF1R at different concentrations before incubation with LLC-MK2
cells. Then, parasites were directly added to LLC-MK2 cells for 1 h of infection. Three
independent experiments were performed in triplicates. The results of cell invasion
(%) were analyzed using t-test and a signiﬁcance level of p < 0.05 for control ().cell invasion (Burleigh et al., 1997; Grellier et al., 2001). Several
cysteine protease inhibitors were discovered to be able to interfere
in T. cruzi biology, especially concerning cell invasion, replication
and differentiation (Aparicio et al., 2004; Monteiro et al., 2001; To-
mas et al., 1997). Based on this knowledge, a cysteine protease
inhibitor named K777 was developed and demonstrated to be a
promising clinical candidate (McKerrow et al., 2009). E-64, a clas-
sical cysteine protease inhibitor, was demonstrated to inhibit T.
cruzi cell invasion due to inhibition of cysteine proteases cruzipains
(Aparicio et al., 2004).
Other results have shown that several T. cruzi trypomastigotes
forms incubated with 10 lM INF1R-rhodamine presented surface
labeling (data not shown). Similar result was observed using
anti-INF1R polyclonal antibodies by indirect immunoﬂuorescence
(data not shown). These results of INF1R impairing cell invasion
and binding to trypomastigotes suggest that INF1R may interact
with the surface of trypomastigotes, probably with a serine
protease.
To elucidate if the reactive site of INF1R is responsible for inhi-
bition of cell invasion, and consequently investigate the mecha-
nism that prevents invasion, a cyclic peptide was synthesized
containing the INF1R reactive site in the structure of the smallest
serine protease inhibitor Sunﬂower Trypsin Inhibitor-1 (SFTI-1), a
Bowman-Birk inhibitor (BBI) formed by 14 amino acid residuesFig. 3. (A) Amino acid sequence alignment of reactive site of different protease
inhibitors. INF1R, infestin 1R, SFTI, Sunﬂower Trypsin Inhibitor, soy BBI, Bowman-
Birk soy bean trypsin inhibitor, LDTI, Leech-derived tryptase inhibitor. The amino
acid residues at P2, P1, P10 e P20 positions of reactive site are the important residues
to interact with serine proteases. (B) SFTI-like peptide designed based on amino
acid alignment of infestin 1R and SFTI-1 according to (Korsinczky et al., 2001). (C)
Effect of 1RSFTI on epithelial cells invasion by T. cruzi trypomastigotes strain Y.
Three independent experiments were performed in triplicates. The results of cell
invasion (%) were analyzed using t-test and a signiﬁcance level of p < 0.05 for
control ().
Fig. 4. Inhibition curves of T. cruzi cell invasion for two subtilisin inhibitors, INF1R and CmPI–II. Graphic shows inhibitory activity toward T. cruzi cell invasion versus log of
protease inhibitor concentrations. The assays were performed with freshly released parasites in a host/parasite cell ratio of 1/10 (approximately 5  106/ml) and parasites
were pre-incubated for 15 min with INF1R in different concentrations (0.1–10 lM INF1R or 3.0–13 lM CmPI2) before incubation with LLC-MK2 cells. Then, parasites were
directly added to LLC-MK2 cells for 1 h at 37 C. These data represent two independent experiments in triplicates.
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1RSFTI, was designed taking into account the similarity between
the amino acid sequence of reactive sites of Kazal-type and BBI
inhibitor families previously described (Korsinczky et al., 2001)
(Fig. 3A). We have replaced the amino acid Cys for Gly in order
to promote the cyclization of the recombinant peptide named
1RSFTI (Fig. 3B). 1RSFTI 100 lM used in cell invasion by T. cruzi as-
say impairs more than 50% invasion (Fig. 3C). Differences in the
inhibitory activity between INF1R and 1RSFTI occur probably due
to interaction with other regions in the INF1R structure. Despite
that, 1RSFTI could be a target molecule to design new molecules
able to block T. cruzi cell invasion and elucidate the involved
mechanism.
In sum, the inﬂuence of INF1R on cell invasion by T. cruzimay be
imputed to the inhibition of parasite proteases. Another serine pro-
tease inhibitor, TiPI1, which belongs to pacifastin-like inhibitors
family (I19, according to the MEROPS database) and is a strong
elastase inhibitor (Ki = 0.4 nM) similar to INF1R but without subtil-
isin inhibitory activity (de Marco et al., 2010), was used in the cell
invasion assay. T. cruzi cell invasion was inhibited in culture media
containing up to TiPI1 8 lM ﬁnal concentration, (data not shown).
Another serine protease inhibitor used in invasion assays was
CmPI-II, a trypsin (Ki = 1.1 nM), elastase (Ki = 2.6 nM), and subtili-
sin A (Ki = 30.8 nM) inhibitor (Gonzalez et al., 1997). CmPI-II was
able to impair T. cruzi cell invasion and presented an IC50 around
10 lM (Fig. 4). When compared to INF1R, CmPI2 presented lower
inhibitory activity, probably due to the tenfold difference in the
subtilisin inhibitory constant (Ki).
More experiments should be conducted to identify the INF1R
target molecule in the T. cruzi, to demonstrate and clarify possible
new roles of INF1R and related molecules in this Chagas disease
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